ARCHIVES

NIH Cool On OIG, But the Awardees Love it, DeVita Says

This article is from The Cancer Letter archive.

Vol. 12 No. 40 | October 17, 1986

Download PDF Visit The Full Archive

Related Articles

NIH director; Targets Increases Favor Established Researchers

May 9, 1997

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

April 28, 2006

NCI Programs:Institute Informs Public About Thyroid Cancer Risk From Fallout.

January 3, 2003

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

January 27, 2012

Certification Means More Money for Nurses, ONS Finds

June 29, 1990

CCOP 2 Under Way After Bitter Recompetition Cancer Control Protocols Being Review; PLs, Affiliates Listed

February 19, 1988